Cedars-Sinai ACO Public Reporting Requirements

Cedars-Sinai Accountable Care, LLC

200 N. Robertson Blvd. Ste 101
Beverly Hills, CA 90211


Contact:

ACO Primary Contact:
John E. Jenrette, MD
Phone: 310-385-3355
Email: john.jenrette@cshs.org


ACO Participants

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Alexander Philip Ford MD N
Aliza A Lifshitz, MD N
Anne L Peters, MD N
Cardiovascular Medical Group of Southern California N
Cedars-Sinai Medical Care Foundation N
Daniel A.S. Hoffman, A Medical Corporation N
David Schechter, MD N
Dorothy H. Lowe, MD, A Medical Corporation N
Entertainment Medical Group Inc N
Farhad Melamed M.D., A Medical Corporation N
Glen Wool N
Jack Ditlove MD N
James L. Meltzer, MD, Inc. N
Keith L Klein MD FACP FASN Inc N
Lyle D. Kurtz, MD, Inc. N
Malak Philippe Zacca Shammas MD N
Michel J. Mazouz, MD, A Medical Corporation N
One Medical Group, Inc. N
Paul Cohart MD Inc. N
Ramin Gabbai MD., a Medical Corporation N
Rita R Kumar MD Inc N
Roger L Lerner, MD, FACP N
Samuel Ross N
Samuel Ross MD Inc N
Steven J Jacobs MD Inc. N
Steven M. Simons MD Inc. N
Wendy Cheng, MD, A Professional Corporation N


ACO Governing Body

Member Member's Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Thomas Priselac, Chairman of the Board and President 1 ACO Participant Representative Cedars-Sinai Medical Center
Thomas Gordon, Executive Director and CEO 1 ACO Participant Representative Cedars-Sinai Medical Care Foundation
Edward Prunchunas, Chief Financial Officer 1 ACO Participant Representative Cedars-Sinai Medical Center
Peter Braveman, Secretary 1 ACO Participant Representative Cedars-Sinai Medical Center
Robert Eller 1 Medicare Beneficiary Representative N/A
Vera Guerin 1 ACO Participant Representative Cedars-Sinai Medical Care Foundation
Richard Jacobs 1 ACO Participant Representative Cedars-Sinai Medical Center
Michael Langberg, MD 1 ACO Participant Representative Cedars-Sinai Medical Center
Thomas Leanse 1 ACO Participant Representative Cedars-Sinai Medical Care Foundation
Gerald Whitman, MD 1 Other - IPA Representative N/A
Stewart Middler, MD 1 ACO Participant Representative Cedars-Sinai Medical Care Foundation
James Nathan 1 ACO Participant Representative Cedars-Sinai Medical Care Foundation
Lawrence Platt 1 ACO Participant Representative Cedars-Sinai Medical Care Foundation
Mark Siegel 1 ACO Participant Representative Cedars-Sinai Medical Center
Theodore Stein, MD 1 ACO Participant Representative Cedars-Sinai Medical Care Foundation
Leslie Vermut 1 ACO Participant Representative Cedars-Sinai Medical Center


Key ACO Clinical and Administrative Leadership

  • John Jenrette, ACO Executive
  • Stephen Deutsch, Medical Director
  • Suzanne Futterman, Compliance Officer
  • Caroline Goldzweig, MD, Quality Assurance/Improvement Officer


Associated Committees and Committee Leadership

Committee Name Committee Leader Name and Position
Clinical Excellence Council Chaired by John Jenrette, MD
Clinical Performance Committee Chaired by Stephen Deutsch, MD, and Clement Yang, MD
Patient Safety Committee Chaired by Myles Cohen, MD
Population Health Alignment and Strategic Execution Chaired by Brad Rosen, MD, Sharon Isonaka, MD, and Cynthia Deculus



Types of ACO Participants or Combinations of Participants that formed the ACO

1. ACO professionals in a group practice arrangement

2. Networks of individual practices of ACO professionals

3. Hospital employing ACO professionals


Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2016, $0
  • First Agreement Period
    • Performance Year 2015, $0
    • Performance Year 2014, $0
    • Performance Year 2013, $0

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2013
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2016 Quality Performance Results

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 84.41 79.9
ACO-2 CAHPS: How Well Your Providers Communicate 93.29 92.63
ACO-3 CAHPS: Patients' Rating of Provider 93.1 91.93
ACO-4 CAHPS: Access to Specialists 87.54 83.52
ACO-5 CAHPS: Health Promotion and Education 57.94 60
ACO-6 CAHPS: Shared Decision Making 73.38 75.28
ACO-7 CAHPS: Health Status/Functional Status 70.9 71.82
ACO-34 CAHPS: Stewardship of Patient Resources 28.4 27.52
ACO-8 Risk-Standardized, All Condition Readmission 15.16 14.7
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) 18.88 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 59.68 53.2
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 80 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 64.38 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 6.31 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 11.04 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 75 82.72
ACO-39 Documentation of Current Medications in the Medical Record 85.93 87.54
ACO-13 Falls: Screening for Future Fall Risk 49.26 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization 60.71 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults 56.79 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up 81.44 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 94.25 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 29.85 53.63
ACO-19 Colorectal Cancer Screening 61.49 61.52
ACO-20 Breast Cancer Screening 60.24 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented 90.65 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 82.7 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 20.18 18.24
ACO-41 Diabetes: Eye Exam 30 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 72.85 70.52
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 80.25 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 91.61 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 76.44 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for "Cedars-Sinai Accountable Care, LLC" or "Cedars-Sinai Medical Care Foundation" to view the quality performance results. This ACO can also be found by using the ACO ID A42036 in the public use files on data.cms.gov.

Payment Rule Waivers

No, our ACO does not utilize the SNF 3-Day Rule Waiver